INVECTYS THERAPEUTICS
Invectys is a biopharmaceutical company focused on the development of innovative immunotherapy approaches to treat cancers. It was founded in 2010 by Pierre Langlade Demoyen and Simon Wayne-Hobson and is based in Paris. Invectys develops a novel approach to mobilizing and restoring the anti-tumor capacity of the immune system of cancer patients. This allows virtually all cancers to be targeted. Invectys focuses its efforts on two highly prevalent tumor antigens: the nearly-universal tumor antigen telomerase that is critical to uncontrolled cell growth, and the HLA-G immune checkpoint expressed in over 50% of cancers.
INVECTYS THERAPEUTICS
Social Links:
Industry:
Biopharma Biotechnology Life Science Pharmaceutical Therapeutics
Founded:
2010-01-01
Address:
Houston, Texas, United States
Country:
United States
Website Url:
http://www.invectys.com
Total Employee:
11+
Status:
Active
Contact:
585-278-3001
Total Funding:
64.28 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt WordPress Google Universal Analytics Apache
Similar Organizations
Axcella
Axcella is a biotechnology company providing therapeutics development solutions.
Netnoids Rx Laboratories
Netnoids Rx Laboratories uses patient-derived organoid model systems to help find a cure for rare cancers.
Simcha Therapeutics
Simcha Therapeutics is a biopharmaceutical company developing engineered cytokine immunotherapy for cancer.
Current Advisors List
Current Employees Featured
Founder
Key Employee Changes
| Date | New article |
|---|---|
| 2022-03-01 | Invectys appoints Jian Cao, Ph.D., as Vice President, Pharmaceutical Development |
Official Site Inspections
http://www.invectys.com Semrush global rank: 4.43 M Semrush visits lastest month: 2.5 K
- Host name: cluster010.hosting.ovh.net
- IP address: 213.186.33.19
- Location: France
- Latitude: 48.8582
- Longitude: 2.3387
- Timezone: Europe/Paris
